Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations

被引:44
|
作者
Valbuena, Alberto
Lopez-Sanchez, Inmaculada
Vega, Francisco M.
Sevilla, Ana
Sanz-Garcia, Marta
Blanco, Sandra
Lazo, Pedro A.
机构
[1] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain
[2] Univ Salamanca, CSIC, Ctr Invest Canc, Programa Oncol Translac, E-37007 Salamanca, Spain
关键词
VRK1; antibody; epitopes; immunohistochemistry; subcellular localization;
D O I
10.1016/j.abb.2007.06.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human VRK1 is a new ser-thr kinase expressed in many cell types. VRK1 is a regulator of p53 and other transcription factors related with cellular responses to stress. The human VRK1 protein has a dominant epitope located in its C-terminal region, between residues 333 and 396, which is detected by different antibodies. All the antibodies detect the same protein in immunoblots and immunoprecipitations. But the antibodies have a different reactivity when a single aminoacid substitution in T355, mimicking phosphorylation, is introduced next to the nuclear localization signal. These differences in reactivity permit the identification of different intracellular subpopulations. Most of the intracellular VRK1 protein is nuclear, but in some cells it is also detected in the cytosol, depending on the type of tissue. These different locations are detected by immunohistochemistry of human biopsies and immunofluorescence of cell lines. Some antibodies identify a subpopulation within the vesicular system, particularly in the Golgi apparatus. The different reactivity of the VRK1 protein indicates that this protein has a subcellular localization that can be regulated, thus adding an additional level of regulatory complexity to the VRK1 protein. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [41] The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines
    Blanco, Sandra
    Klimcakova, Lucia
    Vega, Francisco M.
    Lazo, Pedro A.
    FEBS JOURNAL, 2006, 273 (11) : 2487 - 2504
  • [42] The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF
    Rico, Amber B.
    Linville, Alexandria C.
    Olson, Annabel T.
    Wang, Zhigang
    Wiebe, Matthew S.
    JOURNAL OF VIROLOGY, 2021, 95 (03)
  • [43] p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop
    Valbuena, Alberto
    Vega, Francisco M.
    Blanco, Sandra
    Lazo, Pedro A.
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (13) : 4782 - 4793
  • [44] Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition
    Lee, Namgyu
    Kwon, Jung-Hee
    Kim, Young Bae
    Kim, Seong-Hoon
    Park, Sung Jin
    Xu, Weiguang
    Jung, Hoe-Yune
    Kim, Kyong-Tai
    Wang, Hee Jung
    Choi, Kwan Yong
    ONCOTARGET, 2015, 6 (30) : 30130 - 30148
  • [45] Mitogen-activated protein kinase phosphatase 2 regulates histone H3 phosphorylation via interaction with vaccinia-related kinase 1
    Jeong, Min-Woo
    Kang, Tae-Hong
    Kim, Wanil
    Choi, Yoon Ha
    Kim, Kyong-Tai
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24 (03) : 373 - 384
  • [46] Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation
    Hengqing Zhu
    Qing Li
    Yulan Zhao
    Hong Peng
    Liangyun Guo
    Jing Zhu
    Zi Jiang
    Zhaoxia Zeng
    Bin Xu
    Sisi Chen
    Oncogene, 2021, 40 : 4663 - 4674
  • [47] Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation
    Zhu, Hengqing
    Li, Qing
    Zhao, Yulan
    Peng, Hong
    Guo, Liangyun
    Zhu, Jing
    Jiang, Zi
    Zeng, Zhaoxia
    Xu, Bin
    Chen, Sisi
    ONCOGENE, 2021, 40 (28) : 4663 - 4674
  • [48] NEW MISSENSE MUTATIONS IN THE VACCINIA-RELATED KINASE 1 GENE ARE ASSOCIATED WITH AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE
    El Bazzal, L.
    Castro, C.
    Roeckel, N.
    Desvignes, J. P.
    Megarbane, A.
    Jabbour, R.
    Delague, V
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 (03) : 251 - 252
  • [49] Downregulating vaccinia-related kinase 1 by luteolin suppresses ovarian cancer cell proliferation by activating the p53 signaling pathway
    Chang, Xuboya
    Tamauchi, Satoshi
    Yoshida, Kosuke
    Yoshihara, Masato
    Yokoi, Akira
    Shimizu, Yusuke
    Ikeda, Yoshiki
    Yoshikawa, Nobuhisa
    Kiyono, Tohru
    Yamamoto, Yusuke
    Kajiyama, Hiroaki
    GYNECOLOGIC ONCOLOGY, 2023, 173 : 31 - 40
  • [50] Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells
    Kim, Seong-Hoon
    Ryu, Hye Guk
    Lee, Juhyun
    Shin, Joon
    Harikishore, Amaravadhi
    Jung, Hoe-Youn
    Kim, Ye Seul
    Lyu, Ha-Na
    Oh, Eunji
    Baek, Nam-In
    Choi, Kwan-Yong
    Yoon, Ho Sup
    Kim, Kyong-Tai
    SCIENTIFIC REPORTS, 2015, 5